Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its ...

Medtronic (NYSE: MDT) announced results from a registry highlighting the effectiveness of the Prevail drug-coated balloon ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

Medtronic VP Jason Fontana offered advice for other device developers who might one day be looking for their own NCA.

Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...

Medtronic's surgical device sales decline due to inventory issues CEO Martha monitors impact of Trump's tariffs Shares down more than 7% in morning trade Feb 18 (Reuters) - Medtronic (MDT.N ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Medtronic (MDT) beat estimates for profits ... which includes things like catheters or energy sources to treat abnormal heart rhythms, saw “low-20s” percentage growth.